Scientific Industries INC

Scientific Industries, Inc. has appointed Carr, Riggs & Ingram, LLC as its new independent registered public accounting firm, following the acquisition of its previous auditor's capital markets practice.

Scientific Industries, Inc. completed the sale of its Genie Division assets to Troemner, LLC for $9.6 million plus potential earn-outs, significantly improving its pro forma cash position and net income.

Scientific Industries, Inc. announced the appointment of Zachary Rovinsky as its new Chief Financial Officer and a change in its independent registered public accounting firm.

Scientific Industries, Inc. has divested its Genie Division of Benchtop Laboratory Equipment to Troemner, LLC for $9.6 million in cash plus an earn-out of up to $1.5 million.

Scientific Industries, Inc. extends employment agreements for its President/CEO and Chairman, while also appointing its President/CEO as interim CFO following the departure of Nicholas Lavacca.

Scientific Industries, Inc. has entered into a Securities Purchase Agreement to sell units consisting of common stock, pre-funded warrants, and warrants for a total consideration of $1.55 million.

Scientific Industries reports a reduced net loss of $1.59 million for Q1 2026, driven by revenue growth and cost-cutting initiatives.

Scientific Industries reports a significant net income for Q3 2025 driven by the sale of its Genie product line, despite ongoing operational losses in continuing segments.

Scientific Industries, Inc. reported a wider net loss for Q2 2025 and announced the sale of its Genie Division assets for up to $11.1 million, while also completing a $1.55 million private placement.

Scientific Industries reports a net loss of $1.78 million for Q1 2025, slightly improved from the previous year, while acknowledging substantial doubt about its ability to continue as a going concern.

Scientific Industries saw a significant reduction in its loss from continuing operations in the third quarter of 2024, driven by cost reductions and increased revenue in both operating segments.

Scientific Industries, Inc. reports a reduced loss for the second quarter of 2024, driven by strategic cost reductions and despite a decrease in overall revenue.

Scientific Industries, Inc. reported a significantly reduced net loss for fiscal year 2025, driven by the sale of its Genie product line and continued investment in its Bioprocessing Systems segment.

Scientific Industries reports a decrease in net loss for fiscal year 2024, driven by cost reductions in its Bioprocessing Systems operations, while navigating challenges in its Benchtop Laboratory Equipment segment.

Scientific Industries files an amendment to its annual report to include cybersecurity disclosures, while also providing a detailed overview of its financial performance and business operations.

Scientific Industries, Inc. reported its full year 2023 results, highlighting a slight revenue increase and ongoing investments in its bioprocessing segment despite continued losses.

John A. Moore, Chairman of the Board and Officer of Scientific Industries Inc., reported a transaction involving the acquisition of 4,000 shares of common stock.

Helena R. Santos, President and CEO of Scientific Industries Inc., was granted 130,000 stock options with a $0.6 exercise price, vesting over four years.

Scientific Industries Inc. CEO and President Helena Santos was granted 50,000 stock options with an exercise price of $0.6, vesting over one year.

SCIENTIFIC INDUSTRIES INC's Chairman, John A. Moore, acquired 9,000 shares of common stock at $0.58 per share, increasing his beneficial ownership.

Scientific Industries' Chief Financial Officer, Zachary Rovinsky, was granted 25,000 stock options with a $0.6 exercise price, vesting over a four-year cliff period.

SCIENTIFIC INDUSTRIES INC Director Michael Blechman acquired 44,000 stock options as compensation, increasing his beneficial ownership to 116,186 derivative securities.

Scientific Industries, Inc. announces its 2024 Annual Meeting of Shareholders for January 22, 2026, to vote on director elections, an expanded equity incentive plan, and auditor ratification.

Scientific Industries, Inc. will hold its 2023 Annual Meeting of Stockholders virtually on May 17, 2024, to elect directors and ratify the appointment of its independent auditor.

Scientific Industries, Inc. (SCND) filed an S-1/A registration statement for the resale of 3.1 million shares by existing stockholders, highlighting ongoing financial losses, a going concern risk, and a strategic pivot towards its Bioprocessing Systems segment despite current revenue declines.

Scientific Industries, Inc. filed an S-1/A registration statement for the resale of up to 3.1 million shares of common stock by selling stockholders, emphasizing its strategic shift towards the Bioprocessing Systems segment despite ongoing net losses and a stated need for additional funding to continue as a going concern.

Scientific Industries, Inc. has filed an S-1/A registration statement for the resale of up to 3.1 million shares of common stock by selling stockholders, while reporting continued net losses and acknowledging substantial doubt about its ability to continue as a going concern.

Scientific Industries, Inc. has filed an S-1 registration statement for the resale of 3.1 million shares by existing stockholders, revealing continued operating losses, a significant accumulated deficit, and a stated need for additional capital to fund its bioprocessing growth initiatives.

Scientific Industries has filed an amendment to its registration statement for the resale of up to 8,035,000 shares of common stock, including shares issuable upon exercise of warrants, by selling stockholders.

Scientific Industries has filed an amendment to its registration statement for the resale of up to 8,035,000 shares of common stock, including shares issuable upon exercise of warrants, by selling stockholders.

Bleichroeder LP and its affiliates have increased their beneficial ownership in Scientific Industries, Inc. to 2,715,026 shares, representing 21.19% of the outstanding common stock.

Three members of the Pessin family, including Brian L. Pessin and Norman H. Pessin, increased their beneficial ownership in Scientific Industries Inc., citing undervaluation.

Three members of the Pessin family have significantly increased their beneficial ownership in Scientific Industries Inc., acquiring additional shares and warrants, citing the stock as an attractive and undervalued investment opportunity.

Bleichroeder LP and its affiliates have increased their beneficial ownership in Scientific Industries, Inc. to 22.69% through a new securities purchase agreement for $250,000, acquiring 250,000 shares and warrants.

Bleichroeder LP, along with Bleichroeder Holdings LLC and Andrew Gundlach, filed Amendment No. 2 to their Schedule 13D, reaffirming beneficial ownership of 2,465,026 shares, representing 20.95% of Scientific Industries, Inc.'s Common Stock.

North Run Capital and affiliated entities have reported a 9.99% beneficial ownership stake in Scientific Industries, Inc., comprising common stock and exercisable warrants.

North Run Capital and affiliated entities have reported a 9.99% beneficial ownership stake in Scientific Industries, Inc., comprising common stock and exercisable warrants.

A group of investment entities and individuals, led by North Run Capital, LP, has filed an amended Schedule 13G disclosing a 9.99% beneficial ownership stake in Scientific Industries, Inc.

Thomas A. Satterfield, Jr. has filed an amended Schedule 13G, disclosing a beneficial ownership of 9.9% of Scientific Industries, Inc.'s common stock as of December 31, 2024.